Your browser doesn't support javascript.
loading
VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer.
Jlassi, Aida; Manai, Maroua; Morjen, Maram; Sahraoui, Ghada; Elasmi Allal, Monia; ELBini-Dhouib, Ines; Naija, Lamia; Charfi, Lamia; Rejaibi, Rim; Ben Ahmed, Melika; Marrakchi, Naziha; Srairi-Abid, Najet; Mezlini, Amel; Manai, Mohamed; Mrad, Karima; Doghri, Raoudha.
Afiliação
  • Jlassi A; Department of Biology, Mycology, Pathologies and Biomarkers Laboratory (LR16ES05), Faculty of Sciences of Tunis, University of Tunis El Manar, Ariana, Tunisia.
  • Manai M; Research Laboratory of Precision Medicine/Personalized Medicine and Oncology Investigation (LR21SP01), Tunis, Tunisia.
  • Morjen M; Department of Biology, Mycology, Pathologies and Biomarkers Laboratory (LR16ES05), Faculty of Sciences of Tunis, University of Tunis El Manar, Ariana, Tunisia.
  • Sahraoui G; Human Genetics Laboratory (LR99ES10), Faculty of Medicine of Tunis, University of Tunis, El Manar, Tunis, Tunisia.
  • Elasmi Allal M; Department of Medicine, Division of Hematology-oncology, New York, New York, United States of America.
  • ELBini-Dhouib I; Laboratory of Biomolecules, Venoms and Theranostic Applications (LR20IPT01), Pasteur Institute of Tunis, University of Tunis, El Manar, Tunis, Tunisia.
  • Naija L; Research Laboratory of Precision Medicine/Personalized Medicine and Oncology Investigation (LR21SP01), Tunis, Tunisia.
  • Charfi L; Department of Pathology, Salah Azaiez Institute, Tunis, Tunisia.
  • Rejaibi R; Faculty of Medicine of Tunis, University of Tunis, El Manar, Tunis, Tunisia.
  • Ben Ahmed M; Biochemistry Laboratory, La Rabta Hospital, Tunis, Tunisia.
  • Marrakchi N; Laboratory of Biomolecules, Venoms and Theranostic Applications (LR20IPT01), Pasteur Institute of Tunis, University of Tunis, El Manar, Tunis, Tunisia.
  • Srairi-Abid N; Faculty of Medicine of Tunis, University of Tunis, El Manar, Tunis, Tunisia.
  • Mezlini A; Department of Surgical Oncology, Salah Aziz Institute, Tunis, Tunisia.
  • Manai M; Research Laboratory of Precision Medicine/Personalized Medicine and Oncology Investigation (LR21SP01), Tunis, Tunisia.
  • Mrad K; Department of Pathology, Salah Azaiez Institute, Tunis, Tunisia.
  • Doghri R; Faculty of Medicine of Tunis, University of Tunis, El Manar, Tunis, Tunisia.
PLoS One ; 18(3): e0278849, 2023.
Article em En | MEDLINE | ID: mdl-36952478
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Leucócitos Mononucleares Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Tunísia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Leucócitos Mononucleares Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Tunísia